# ![@AmanChauhanMD Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1008176501303504896.png) @AmanChauhanMD Aman Chauhan

Aman Chauhan posts on X about watch, education, thomas, in the the most. They currently have [-----] followers and [--] posts still getting attention that total [------] engagements in the last [--] hours.

### Engagements: [------] [#](/creator/twitter::1008176501303504896/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1008176501303504896/c:line/m:interactions.svg)


### Mentions: [--] [#](/creator/twitter::1008176501303504896/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1008176501303504896/c:line/m:posts_active.svg)


### Followers: [-----] [#](/creator/twitter::1008176501303504896/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1008176501303504896/c:line/m:followers.svg)


### CreatorRank: undefined [#](/creator/twitter::1008176501303504896/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1008176501303504896/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[nba](/list/nba)  [countries](/list/countries)  [travel destinations](/list/travel-destinations) 

**Social topic influence**
[watch](/topic/watch), [education](/topic/education), [thomas](/topic/thomas), [in the](/topic/in-the), [supported](/topic/supported), [the best](/topic/the-best), [complex](/topic/complex), [the latest](/topic/the-latest), [canada](/topic/canada), [vegas](/topic/vegas)

**Top accounts mentioned or mentioned by**
[@sylvestercancer](/creator/undefined) [@nanets1](/creator/undefined) [@curenets](/creator/undefined) [@amanchauhanmd](/creator/undefined) [@ncfcancer](/creator/undefined) [@ncukcharity](/creator/undefined) [@jaydidelrivero](/creator/undefined) [@helops79](/creator/undefined) [@netconnectinfo](/creator/undefined) [@glopesmd](/creator/undefined) [@netcanceraware](/creator/undefined) [@oncbrothers](/creator/undefined) [@carcinoidnets](/creator/undefined) [@lacnets](/creator/undefined) [@ukmarkey](/creator/undefined) [@profkherrmann](/creator/undefined) [@asco](/creator/undefined) [@healingnet1](/creator/undefined) [@umiamimedicine](/creator/undefined) [@oncothor](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Checkout our two #neuroendocrinetumor posters this morning. #Asco19 #nets #ASCO19 @LowellAnthonyMD @AmanChauhanMD https://t.co/Qp4pMloSq5 #ASCO19 @LowellAnthonyMD @AmanChauhanMD https://t.co/Qp4pMloSq5"  
[X Link](https://x.com/AmanChauhanMD/status/1135514400922787842)  2019-06-03T11:51Z [----] followers, [--] engagements


"Our rockstar NET investigator and NETCONNECT mentor @Ja_Capdevila presenting his very promising Phase II data on Lenvatinib. ORR:16% (centrally reviewed) and PFS: 15m. #NETs. Thanks to @ASCO for focusing on rare tumors. #ASCO19 #ascoispy @net_connectinfo @CarcinoidNETs"  
[X Link](https://x.com/AmanChauhanMD/status/1135599964619452417)  2019-06-03T17:31Z [----] followers, [--] engagements


"@drjasonstarr Thanks Jason. All fantastic ideas We are designing prrt sensitizer trials. Novel agonist and antagonist seems to be promising. I hope alpha particle NET drug dev also kicks off in the US soon. Lastly PRRT seems to have immunomodulatory effectmay be promising for IC combo trial"  
[X Link](https://x.com/AmanChauhanMD/status/1236744781004496896)  2020-03-08T20:05Z [----] followers, [--] engagements


"Day2 NCAN patient conf. Amazing job as always NCAN. [--] years and running Thanks @LACNETS @HealingNET1 @NANETS1 @CarcinoidNETs for support and all wonderful patients who came all the way to support us 🙏 @netcanceraware @UKMarkey UKMarkey #NETs"  
[X Link](https://x.com/AmanChauhanMD/status/1518208792244240384)  2022-04-24T12:42Z [----] followers, [--] engagements


"We are excited for NCAN Michigan. Come meet us there on June 25th #PatientConference #NETs @netcanceraware @UKMarkey"  
[X Link](https://x.com/AmanChauhanMD/status/1532026209000902657)  2022-06-01T15:48Z [----] followers, [--] engagements


"Thanks @nbc6 for helping us raise awareness about neuroendocrine cancers. Today we discussed Merkle Cell Carcinoma a rare neuroendocrine cancer of skin and how to protect ourselves. We lost legendary singer Jimmy Buffett to Merkle Cell Ca. @SylvesterCancer @umiamimedicine"  
[X Link](https://x.com/AmanChauhanMD/status/1699591329037066570)  2023-09-07T01:12Z [----] followers, [----] engagements


"Had a great time discussing PRRT related toxicity and how to mitigate it. @NANETS1 @SylvesterCancer"  
[X Link](https://x.com/AmanChauhanMD/status/1700190306413539618)  2023-09-08T16:52Z [----] followers, [----] engagements


"And its a wrap. Till we meet next year at Chicago for NANET24. Congratulations @PamelaKunzMD on finishing a successful NET presidency tenure and taking @NANETS1 to stratospheric heights. We couldnt have asked for a better successor. Congratulations @OncoThor and so excited for our field 🦓 @JaydiDelRivero @HKennecke"  
[X Link](https://x.com/AmanChauhanMD/status/1710675707926319451)  2023-10-07T15:17Z [----] followers, [----] engagements


"Glad to have full support of @SylvesterCancer We are proud to have a multidisciplinary Neuroendocrine Cancer program in Miami with focus on both NETs & NECs access to weekly NET Tumor Board and cutting edge clinical trials. @netcanceraware @LACNETS @HealingNET1 @NANETS1 @CureNETs @net_connectinfo @PheoPara When it comes to rare #cancers such as #NeuroendocrineTumors (NET) Sylvester is already ahead to provide the best #PatientCare. Our new NET clinic led by @AmanChauhanMD offers the latest translational treatments and quality care found only at Sylvester.https://t.co/VhmyanlRXS When it comes"  
[X Link](https://x.com/AmanChauhanMD/status/1712580332740890992)  2023-10-12T21:25Z [----] followers, [----] engagements


"After spending some time in Canada at NANETS and then a little vacation in Tulum its back to work mode. Who says Neuroendocrine Cancers are rare Christmas present came early so grateful to my scribe 🙏😀🦓 #MiamiNETs @SylvesterCancer"  
[X Link](https://x.com/AmanChauhanMD/status/1712958080437141536)  2023-10-13T22:26Z [----] followers, [----] engagements


"Save the date. Join us on Feb 23-24 in sunny Orlando for a thorough review of practice informing data in GI Cancers. Also dont miss out an opportunity to meet @EileenMOReilly @CathyEngMD @GABOUALFA Dr Philip Philip et al. Shoutout to our wonderful conference organizers @rutikamehtaMD @Dr_M_Tejani @HaniBabiker @Jcj84Jeremy @HorizonCME 🔬 Explore the latest breakthroughs in cancer research. 👥 Network with leading oncologists and researchers. 📚 Gain insights into practice informing data. 🗣 Engage in dynamic discussions and panels. 🎓 Earn CME credits. @SylvesterCancer"  
[X Link](https://x.com/AmanChauhanMD/status/1716777748121711045)  2023-10-24T11:24Z [----] followers, [----] engagements


"@GlopesMd hosts the best oncology symposiums. Come join us in Miami to learn latest and greatest of thoracic oncology. We had a great year and will summarize key updates from ASCO AACR WCLC and ESMO. What a way to wrap up [----]. I will specifically talk about Thoracic High Grade Neuroendocrine Neoplasms; Small Cell Lung Cancer. See ya there 🦓 @OncLiveSOSS"  
[X Link](https://x.com/AmanChauhanMD/status/1717282559921381658)  2023-10-25T20:50Z [----] followers, [----] engagements


"Another international student successfully rotated through our NETs clinic at @SylvesterCancer He got to witness all types of nets from carcinoids to all the way small and large cell neuroendocrine carcinomas. Six new patients including one from Canada. What a way to wrap up our clinic today. Happy Friday everyone #MiamiNETs 🦓"  
[X Link](https://x.com/AmanChauhanMD/status/1718018297021554761)  2023-10-27T21:34Z [----] followers, [----] engagements


"MGMT status and alkylator activity has been long linked ECOG-ACRIN [----] was probably 1st prospective RCT confirming MGMTd with greater odds to response. However we were missing outcome data with regards to PFS or OS. MGMT NET compels us to consider this biomarker seriously now I was leaning away from prolonged use of CAPTEM (in era of PRRT) regardless due to heightened risk of MDS MGMT status now helps us to trailer treatment. This info will take time to percolate in consensus guidelines but I am leaning towards changing my practice. I will still continue CAPTEM for G3 or biologically"  
[X Link](https://x.com/AmanChauhanMD/status/1718969256442765616)  2023-10-30T12:33Z [----] followers, [----] engagements


"Five years ago we got married and I feel that this will be the best year yet. On a side note almost done with the call Double Cheers 🥂"  
[X Link](https://x.com/AmanChauhanMD/status/1728434221138485304)  2023-11-25T15:23Z [----] followers, [----] engagements


"What a year for NETs 🦓 We had our inaugural @ASCO NET guidelines Latest AJCC @AJCCancer NET Chapters Ver [--] and not one but THREE positive studies: Cabinet NETTER-2 and Paltusotine. If you want to get a quick scoop come join us in Orlando on Feb 23/24 for Highlights in GI Oncology Symposium @HorizonCME @SylvesterCancer Honored to join some of the most prolific GI Onc Experts @CathyEngMD @GABOUALFA @EileenMOReilly Dr Philip Philip Hats off to Symposium Chairs @rutikamehtaMD @HaniBabiker @Jcj84Jeremy @Dr_M_Tejani for pulling off yet another exciting GI Onc symposium. And this year they didnt"  
[X Link](https://x.com/anyuser/status/1750857792993309094)  2024-01-26T12:26Z [--] followers, [--] engagements


"What a year for NETs 🦓 We had our inaugural @ASCO NET guidelines Latest AJCC @AJCCancer NET Chapters (Staging and Outcomes) Ver [--] and not one but THREE positive studies: Cabinet NETTER-2 and Paltusotine. If you want to get a quick scoop come join us in Orlando on Feb 23/24 for Highlights in GI Oncology Symposium @HorizonCME @SylvesterCancer Honored to join some of the most prolific GI Onc Experts @CathyEngMD @GABOUALFA @EileenMOReilly Dr Philip Philip Hats off to Symposium Chairs @rutikamehtaMD @HaniBabiker @Jcj84Jeremy @Dr_M_Tejani for pulling off yet another exciting GI Onc symposium. And"  
[X Link](https://x.com/AmanChauhanMD/status/1750858842462679197)  2024-01-26T12:30Z [----] followers, [----] engagements


"@drtulsijose @hemeoncfellow Thanks for bringing it to my notice. Let me follow up with organizers"  
[X Link](https://x.com/AmanChauhanMD/status/1751091266949919183)  2024-01-27T03:54Z [----] followers, [---] engagements


"Finished another inpatient service on a high. [--] pts on a Sunday So blessed to have wonderful and talented NPs in our team. Also true to my usual trend we had three new neuroendocrine consult this week. 🦓#NETs @SylvesterCancer"  
[X Link](https://x.com/AmanChauhanMD/status/1759290767766401519)  2024-02-18T18:56Z [----] followers, [---] engagements


"Adrenaline rush of a PR and continued tumor shrinkage. So happy for my patient #PRRT #RadiationSensitizers #Theranostics #NETs @SylvesterCancer 🦓☢"  
[X Link](https://x.com/AmanChauhanMD/status/1764736488871223537)  2024-03-04T19:35Z [----] followers, [---] engagements


"Theranostics: Revolutionizing healthcare by combining therapy and diagnostics for personalized treatment. #theranostics #NETs #Radiopharmaceuticals @LACNETS @netcanceraware @CureNETs @CarcinoidNETs @net_connectinfo @PheoPara @NANETS1 Radiopharmaceuticals is a class of drugs that may have the most immediate impact in neuroendocrine tumors. @StephenVLiu leads a discussion about how such therapies play a role in diagnostics/ therapeutics w/@JaydiDelRivero @AmanChauhanMD & @ProfKHerrmann. https://t.co/dPC9OgZatg https://t.co/ATNugLYz4w Radiopharmaceuticals is a class of drugs that may have the"  
[X Link](https://x.com/AmanChauhanMD/status/1765500355612172429)  2024-03-06T22:11Z [----] followers, [----] engagements


"I am excited about the clinical improvements that paltusotine demonstrated for patients with carcinoid syndrome in this study. So happy @SylvesterCancer was part of this international study Congratulations everyone 🥂 #NETs #drugdevelopment @netcanceraware @CureNETs @LACNETS @net_connectinfo @HealingNET1 @CarcinoidNETs @NANETS1 @GrupoGetne @Netespana @netcancerfound @NETsMexico Crinetics announces positive topline results from phase [--] trial of paltusotine for the treatment of carcinoid syndrome. https://t.co/JXfO3qyCEE #CarcinoidSyndrome #CRNX Crinetics announces positive topline results from"  
[X Link](https://x.com/AmanChauhanMD/status/1767699046444015768)  2024-03-12T23:47Z [----] followers, [---] engagements


"Love my NETs colleagues who are always working in collaboration to help advance science ETCTN [-----] tested Peposertib a novel DNA PKi in combination with Lutathera in NET patients. It was a joint effort of @UKMarkey @SylvesterCancer @Huntsman_CTO @cityofhope and OSU The first in human study has completed accrual and stay tuned for data and next steps later this year We are currently enrolling NET patients in ETCTN [-----]. This randomized phase [--] builds on our successful phase [--] study where we are trying to evaluate benefits of adding radiation sensitizer Triapine a RNRi with Lutathera. Come"  
[X Link](https://x.com/AmanChauhanMD/status/1773375052228047335)  2024-03-28T15:42Z [----] followers, [---] engagements


"I am blessed to call The best Para-Pheo expert my friend. Not only she is an excellent clinician-scientist but her willingness to collaborate on preclinical and clinical research is something to emulate. Amazing talk as usual🙌@JaydiDelRivero @NIHClinicalCntr"  
[X Link](https://x.com/AmanChauhanMD/status/1776675252816224483)  2024-04-06T18:16Z [----] followers, [----] engagements


"Fabulous symposium Congratulations to Symposium Chairs @CarmenCalfa @Latinamd @JTrentMDPhD Also made it to my flight just in time beating Miami Formula [--] traffic 🤪😀 #MPM2024 Before running to Boston (from Miami) for another talk @AmanChauhanMD Director of @SylvesterCancer NET program gave an excellent lecture on #PrecisionMedicine Advances in Neuroendocrine Tumors #NETresearch #NeuroendocrineCancer #NETTreatment @NANETS1 https://t.co/PT69LAV60w #MPM2024 Before running to Boston (from Miami) for another talk @AmanChauhanMD Director of @SylvesterCancer NET program gave an excellent lecture on"  
[X Link](https://x.com/AmanChauhanMD/status/1786896323632890032)  2024-05-04T23:10Z [----] followers, [----] engagements


"Wrapped up a busy day @SylvesterCancer NET clinic. Scheduled two PRRT trial patients and also squeezed some time to advise industry on a Phase III study from lobby all while office is getting renovated. @GlopesMd Can I have a putting green in my new office 😉🤪"  
[X Link](https://x.com/AmanChauhanMD/status/1794162701855559833)  2024-05-25T00:24Z [----] followers, [----] engagements


"Honored to be formally inducted as the SWOG NET Committee Co-Chair today. Big shoes to fillthank you Drs. Dasari and Strosberg. I'm excited to advance NETs clinical research and improve outcomes for our patients. 🦓 We are also accepting applications for a NET research position. Join our program #MiamiNETs @SylvesterCancer @SWOG https://umiami.wd1.myworkdayjobs.com/en-US/UMCareerStaff/job/Manager--Research-Support--NET-Program-_R100077359 https://umiami.wd1.myworkdayjobs.com/en-US/UMCareerStaff/job/Manager--Research-Support--NET-Program-_R100077359"  
[X Link](https://x.com/AmanChauhanMD/status/1805631247353311268)  2024-06-25T15:56Z [----] followers, [----] engagements


"5 new patients back to back in a half day clinic. Are NETs really rare @SylvesterCancer"  
[X Link](https://x.com/AmanChauhanMD/status/1814051716708302988)  2024-07-18T21:36Z [----] followers, [----] engagements


"Started my early therapeutics clinic with a partial response Exciting to see new drug developments in NETs aiming for stronger outcomes where traditional therapies have been mostly cytostatic. Progress is on the horizon #NETs 🦓"  
[X Link](https://x.com/AmanChauhanMD/status/1846927828471685507)  2024-10-17T14:54Z [----] followers, [----] engagements


"Happy Diwali from Miami I couldnt have asked for a better start to my day. Started with seeing five patients in our early therapeutics clinic delivering news of three partial responses and two stable diseasesdefinitely a reason to celebrate Might be time to buy a lottery ticket today. 🪔"  
[X Link](https://x.com/AmanChauhanMD/status/1852024046612865340)  2024-10-31T16:25Z [----] followers, [---] engagements


"Happy Diwali from Miami Feeling incredibly lucky to celebrate Diwali [----] with my parents here all the way from India"  
[X Link](https://x.com/AmanChauhanMD/status/1852856249005768909)  2024-11-02T23:32Z [----] followers, [----] engagements


"Thrilled to host Seneca Therapeutics at @SylvesterCancer as we launch our investigator-initiated study of SVV-001 plus Ipi-Nivo in high-grade NENs Enrollment starts next weekfive years of dedication from preclinical research and biomarker validation to protocol development and FDA approval to proceed. Drug development is not for the faint of heart but perseverance pays off. Now the real work begins Thanks to my wonderful colleagues @JTrentMDPhD Drs Jaime Merchan Peter Hosein Wael El Rifai el al for their support and willingness to take the concept forward in their respective areas of"  
[X Link](https://x.com/AmanChauhanMD/status/1898174730332467598)  2025-03-08T00:51Z [----] followers, [----] engagements


"Key takeaways: Not only we have another effective treatment option for all NETs but its a big win specifically for G3 NETs and SSTR-ve Lung Nets which are often ignored in many NET clinical trials #Cabozantinib is now approved in #NET based off #CABINET study We discussed the design findings sequencing and AEs w/ @AmanChauhanMD Full 🗣: https://t.co/AjXESHSbZl Also on the Oncology Brothers podcast #OncTwitter #MedTwitter #gism #GiOnc https://t.co/eKaLnslvPi #Cabozantinib is now approved in #NET based off #CABINET study We discussed the design findings sequencing and AEs w/ @AmanChauhanMD Full"  
[X Link](https://x.com/AmanChauhanMD/status/1910387830473339362)  2025-04-10T17:42Z [----] followers, [----] engagements


"Grateful to the Phase [--] Team at Ohio State University for the opportunity to present on hPG80 a promising new blood-based biomarker. Were excited to validate its role in disease monitoring through ETCTN 10588a multicenter randomized study now nearing completion. Later I had an engaging discussion on advances in NET management with the ever-inspiring Dr. Saab (@GIcancerDoc). We dove into practice-changing data from CABINET NETTER-2 and othersanchoring them in real-world clinical scenarios. Its truly remarkable how far NET oncology has progressed in just over a decade Capped off a fulfilling"  
[X Link](https://x.com/AmanChauhanMD/status/1935739123072966912)  2025-06-19T16:39Z [----] followers, [---] engagements


"Just wrapped up two manuscriptsnothing like a looming deadline to spark productivity. The beautiful Miami view definitely helped keep me focused and motivated. :)"  
[X Link](https://x.com/AmanChauhanMD/status/1947817456304619776)  2025-07-23T00:34Z [----] followers, [----] engagements


"Join us in Las Vegas for an exciting discussion on Radiopharmaceuticals in Drug Developmentone of the fastest-growing sectors in oncology. Register Here https://horizoncme.com/summit-for-novel-therapeutics-in-oncology-precision-medicine-in-cancer/utm_campaign=StopCancer&utm_content=340306444&utm_medium=social&utm_source=twitter&hss_channel=tw-334322044 📣Don't miss a session on "Radiopharmaceuticals in Drug Development" with speaker Dr. @AmanChauhanMD (of @SylvesterCancer ) at this year's STOP Cancer REGISTER TODAY🌐 https://t.co/BEyoiAkZwv STOP Cancer is a multidisciplinary conference that"  
[X Link](https://x.com/AmanChauhanMD/status/1949122006458171505)  2025-07-26T14:57Z [----] followers, [---] engagements


"Such an inspiring group of Hematology-Oncology Fellows Loved the energy and curiosity I hope our discussion sparked some excitement about the world of NETs and Drug Development. Continuing our #HemOncBootcamp Last week we had neuroendocrine cancer expert @AmanChauhanMD lead a phenomenal session on Neuroendocrine Tumors 101- from diagnosis to treatment protocols. He followed it up with inspiring career guidance on becoming a #clinicaltrialist and https://t.co/YfNGzAxNAn Continuing our #HemOncBootcamp Last week we had neuroendocrine cancer expert @AmanChauhanMD lead a phenomenal session on"  
[X Link](https://x.com/AmanChauhanMD/status/1952448289141665993)  2025-08-04T19:15Z [----] followers, [----] engagements


"Excited to join an incredible group of passionate GI oncologists and clinicianscientists in Bermuda. Ill be discussing the emerging role of T cell engager targeting DLL3 in NEC along with new perspectives on TEM-8 and Seneca Valley Virus in Grade [--] neuroendocrine neoplasms. Details https://davabermudagi2025.powerappsportals.com https://davabermudagi2025.powerappsportals.com"  
[X Link](https://x.com/AmanChauhanMD/status/1957963676813521199)  2025-08-20T00:31Z [----] followers, [---] engagements


"We were thrilled to welcome two exceptional fellowsone from Surgical Oncology and one from Hematology-Oncologywho joined us to immerse themselves in the world of neuroendocrine tumors. The growing curiosity and enthusiasm for this field is truly energizing. This week our fellows witnessed patients being consented for innovative clinical trials including Net-Retreat Alpha PRRT DLL-3 BiTE among others. Each trial represents more than scienceit represents hope progress and the promise of a brighter future for our patients. Research continues to be the bridge between todays challenges and"  
[X Link](https://x.com/AmanChauhanMD/status/1963736924369338710)  2025-09-04T22:52Z [----] followers, [----] engagements


"Heading to Las Vegas this week 🌟 Get ready for a sneak peek at the latest and greatest innovations in precision oncology. From cutting-edge breakthroughs to real-world applications. One area I'm particularly passionate abouttheranosticsis gaining serious momentum. In my view (I may be biased 😉) it's the truest form of precision oncology and we're just scratching the surface. Over the next decade expect radiopharmaceuticals to reshape how we treat cancer. I'm truly honored to be speaking alongside an incredible lineup of experts. Ill be diving into Radiopharmaceuticals in Drug"  
[X Link](https://x.com/AmanChauhanMD/status/1970839615880696184)  2025-09-24T13:15Z [----] followers, [----] engagements


"Once considered rare #NeuroendocrineTumors now affect [--] per [------] in the U.S.crossing the traditional orphan disease threshold. Rising incidence reflects better detection awareness & survivorship but also demands more research funding drug access & policy focus. #NETs @GlopesMd @PeterHoseinMD @JaydiDelRivero @NANETS1 @SylvesterCancer https://www.mdpi.com/2072-6694/17/20/3323 https://www.mdpi.com/2072-6694/17/20/3323"  
[X Link](https://x.com/AmanChauhanMD/status/1978497964487143708)  2025-10-15T16:27Z [----] followers, [---] engagements


"Signatera correlated nicely with radiographic stable disease while on CAPTEM till progression in fall [----] then started Lutathera and showed a nice response to [--] doses ()so far. Blood based biomarkers have improved tremendously. Now needs to be validated in prospective RCTs"  
[X Link](https://x.com/AmanChauhanMD/status/1671883349030469632)  2023-06-22T14:10Z [----] followers, [---] engagements


"Once considered rare #NeuroendocrineTumors now affect [--] per [------] in the U.S.crossing the traditional orphan disease threshold. Rising incidence reflects better detection awareness & survivorship but also demands more research funding drug access & policy focus. #NETs Check out the wonderful work from Dr. Yu and colleagues Our star medical student from @UniversityofKY is now making waves at @UofC. Its been an absolute honor to mentor such a talented and driven physicianscientist. @GlopesMd @PeterHoseinMD @JaydiDelRivero @NANETS1 @SylvesterCancer @EndovasClarkY"  
[X Link](https://x.com/AmanChauhanMD/status/1978513038794764678)  2025-10-15T17:27Z [----] followers, [----] engagements


"Buckle up for #ESMO2025 🚀 Follow @OncLive for real-time updates behind-the-scenes moments and expert takes from me and my amazing colleagues all day long Get ready for #ESMO2025 🌟 Follow along on OncLive X this weekend as top oncologists take over with live updates & breakthroughs: 📅 10/17 & [--] Lung & GI: @Jonathanwlee23 📅 10/18 GU: @yekeduz_emre & Breast: @JAMouabbi 📅 10/20 NETs/SCLC & Theranostics: @AmanChauhanMD https://t.co/kEQ1YKnDsx Get ready for #ESMO2025 🌟 Follow along on OncLive X this weekend as top oncologists take over with live updates & breakthroughs: 📅 10/17 & [--] Lung &"  
[X Link](https://x.com/AmanChauhanMD/status/1978923386035130731)  2025-10-16T20:37Z [----] followers, [----] engagements


"Talking about what I love neuroendocrine tumors with none other than Dr. Marshall moderating. Couldnt ask for better company"  
[X Link](https://x.com/AmanChauhanMD/status/1985579164716384639)  2025-11-04T05:25Z [----] followers, [----] engagements


"Happy Thanksgiving to our incredible NET community As we reflect on this season of gratitude my heart is especially full after our recently concluded NET Patient Conference in Miami. Despite travel challenges and busy schedules patients caregivers clinicians researchers and advocates came together with so much energy curiosity and hope. Thank you for the trust you place in us. Thank you for sharing your stories your resilience your questions and your determination. Events like this remind us why we do what we doand why advancing NET and NEC care is not just a professional mission but a deeply"  
[X Link](https://x.com/AmanChauhanMD/status/1994146054758080791)  2025-11-27T20:47Z [----] followers, [----] engagements


"Join me alongside my brilliant colleagues Uday Grewal Renuka Iyer and Shagufta Shaheen as we dive into the complexities of hybrid neuroendocrine cancers. We explore key concepts including histologic transformation mixed tumors and emerging DLL3-targeted therapies drawing on deep expertise from lung cancer and CAR-T perspectives. Tune in to this episode of NETCAST here: https://podcasts.apple.com/us/podcast/hybrid-neuroendocrine-cancers-pathology-grade-transformation/id1647408368i=1000742297698 Perfect start to the new year. Excited to share (my first ever) podcast episode on NETCast (the"  
[X Link](https://x.com/AmanChauhanMD/status/2006775829351772411)  2026-01-01T17:13Z [----] followers, [----] engagements


"t-NET [--] Mitosis/10HPF and Ki67 40%.Morphology intermediate: LCNEC-atypical carcinoid.TMB 23Pt qualifed for our immuno trial.We at @net_connectinfo studying NGS practice pattern in NETs globally. Do u use NGS for NETs/NEC Upfront or Relapse Trials or SOC @pashtoonkasi"  
[X Link](https://x.com/AmanChauhanMD/status/1280971221744615425)  2020-07-08T21:05Z [----] followers, [--] engagements


"Do you treat patients with Neuroendocrine Carcinoma If so we invite you to participate in the survey linked below. Neuroendocrine carcinoma is an aggressive disease with significant unmet clinical needs and advancing research and therapeutic development depends on insights from clinicians actively caring for these patients. Survey link: Thank you for your time and for contributing to progress in this challenging disease area. Please help us spread the word @helops79 @OncoThor @marklewismd @NVijayvergiaMD @JaydiDelRivero @OncBrothers @ajumathew_ @GlopesMd @hosein @Dr_Estelamari_R @NANETS1"  
[X Link](https://x.com/anyuser/status/2016290892660015296)  2026-01-27T23:23Z [----] followers, [----] engagements


"5 years in the making a marriage a child and a job switch later happy to reveal Triapine Randomized Phase II design at ETCTN meeting later today. Will request ETCTN/EDDOP sites to consider this study @SylvesterCancer @UKMarkey @umiamimedicine @UKYMedicine #ETCTN10558 #NET"  
[X Link](https://x.com/AmanChauhanMD/status/1632815693983784960)  2023-03-06T18:49Z [----] followers, [----] engagements


"Met my senior and junior fellows Dr. Darshil Shah and Dr. Garima Gupta at #GIASCO26. In one meeting we designed a multi-institutional observational study and secured a sponsor. This is what makes GI ASCO specialbringing researchers together and making science fun"  
[X Link](https://x.com/AmanChauhanMD/status/2010406209535549453)  2026-01-11T17:39Z [----] followers, [---] engagements


"Advocating for NETs at #GIASCO26 alongside @NANETS1"  
[X Link](https://x.com/AmanChauhanMD/status/2010407383215071428)  2026-01-11T17:44Z [----] followers, [---] engagements


"In case you missed #GIASCO26 we reviewed a large claims database of over [----] patients with NETs who received PRRT. Nearly one-quarter of these patients went on to receive PRRT re-treatment highlighting the high real-world utilization of PRRT driven by its safety and efficacy. However prospective randomized data defining the true benefit of PRRT re-treatment remain lacking. The CCTGSWOG NET-RETREAT study is designed to address this critical evidence gap. Please consider opening this trial at your site and help us answer this important question for our patients. Alsomy first symposium as UCSF"  
[X Link](https://x.com/anyuser/status/2010414250796495354)  2026-01-11T18:11Z [----] followers, [---] engagements


"Join us tomorrow at the NRG Oncology Winter Meeting in San Francisco. @helops79 Theranostics: Where precision imaging meets targeted therapy. Ill be highlighting emerging radiation-sensitizer combinations and their potential to advance patient outcomes. @UCSF #NRG2026 https://www.nrgoncology.org/meetings/2026-winter-nrg-meeting/ https://www.nrgoncology.org/meetings/2026-winter-nrg-meeting/"  
[X Link](https://x.com/anyuser/status/2014016101492163034)  2026-01-21T16:43Z [----] followers, [---] engagements


"A packed house with palpable enthusiasm for Theranostics. An outstanding morning session covering everything from building Theranostics programs to addressing the inevitable growing pains as the field scales. #NRG2026"  
[X Link](https://x.com/AmanChauhanMD/status/2014400309481889816)  2026-01-22T18:10Z [----] followers, [---] engagements


"A masterclass on the evolution of radioligand therapy in NETs and its future directions delivered brilliantly by the fantastic @helops79 #NRG2026 @huntsmancancer"  
[X Link](https://x.com/AmanChauhanMD/status/2014401534235398356)  2026-01-22T18:15Z [----] followers, [---] engagements


"Wrapped up a fantastic day of Theranostics at NRG Oncology with rich discussions around novel radiation-sensitizer strategies. This space is evolving rapidlystay tuned. Looking forward to presenting ETCTN [-----] (Peposertib + Lutathera) data at the upcoming ENETS meeting in Poland"  
[X Link](https://x.com/AmanChauhanMD/status/2014496606708793627)  2026-01-23T00:33Z [----] followers, [---] engagements


"Outnumbered. Out-muscled. Currently mediating a three-way lap custody dispute. 🐶👶👶 #Unpacking #California"  
[X Link](https://x.com/AmanChauhanMD/status/2014822204480061541)  2026-01-23T22:07Z [----] followers, [---] engagements


"Starting my new practice at UCSF later this weekand already feeling incredibly energized. Had the chance to attend a stimulating Division of Hematology and Oncology retreat surrounded by thoughtful driven colleagues. Looking forward to contributing and growing with this outstanding group. Ohand next year Im ditching the suit and tie. #NeuroendocrineTumors #Theranostics"  
[X Link](https://x.com/AmanChauhanMD/status/2018834011024671181)  2026-02-03T23:48Z [----] followers, [----] engagements


"Quick thoughts on some exciting NET/NEC clinical trials Im keeping an eye on in [----]. PostGI ASCO catch-up with fellow NET enthusiasts Dr. Garima Gupta and @lisayentwin from @NCFCancer. 🎥 https://youtu.be/3La4__Xo0mEsi=9dqi4QA-q_OslvrE https://youtu.be/3La4__Xo0mEsi=9dqi4QA-q_OslvrE"  
[X Link](https://x.com/AmanChauhanMD/status/2019641407259177306)  2026-02-06T05:16Z [----] followers, [---] engagements


"Excited to join fellow NET enthusiasts from around the world at the 23rd Annual ENETS Conference in Poland Grateful for the opportunity to present data on two novel concepts spanning both well-differentiated NETs and poorly differentiated NECs. Krakw tipsmust-see spots and great places to eatvery welcome @ENETS_ORG https://enetsconference.org/ https://enetsconference.org/"  
[X Link](https://x.com/anyuser/status/2020918718684070017)  2026-02-09T17:52Z [----] followers, [---] engagements


"RT @net_connectinfo: Are you an oncologist treating patients with neuroendocrine carcinoma Share your insights in this online survey: htt"  
[X Link](https://x.com/anyuser/status/2021254821433483646)  2026-02-10T16:07Z [----] followers, [--] engagements


"Honored to be part of Zeal for Lifea powerful new documentary that captures the journey of neuroendocrine tumor (NET) patients caregivers and the physicians who walk alongside them. Join us for a special teaser screening in Los Angeles on March [--] as we spotlight resilience hope and the human stories behind NET care. Grateful to share this space with inspiring patients caregivers and colleagues who live this mission every day. @rainbennett @lisayentwin @NCFCancer Register here for the event: #ZealForLife #NeuroendocrineTumors #NETs #PatientStories #CaregiverVoices #Oncology #LAEvents"  
[X Link](https://x.com/anyuser/status/2021327446482862316)  2026-02-10T20:56Z [----] followers, [---] engagements


"After successfully completing our 200-patient NEC survey our physician survey of providers who treat NEC has now reached its accrual goal of [---] participants. Now comes the best partdata cleaning analysis and uncovering insights. Looking forward to sharing what we learn at a meeting later this year. Thank you again to everyone who took the time to participate"  
[X Link](https://x.com/anyuser/status/2022451481522377022)  2026-02-13T23:23Z [----] followers, [---] engagements


"@greeneannac Thanks. Many academic participants (NANETS members) focus on extrapulm (the intention of the study) but I am sure many participants especially community oncology colleagues treat site agnostic NEC"  
[X Link](https://x.com/AmanChauhanMD/status/2022717757809393763)  2026-02-14T17:01Z [----] followers, [--] engagements


"📣 Video podcast 📣 Understanding EP-NEC: Through diagnosis treatment and support w/ Medical Oncologist Dr @AmanChauhanMD + Neuroendocrine Patient Advocate Susan Meckler-Plummer RN 📹 Highlights in this post Watch the full video or listen on Spotify/Apple: 🤝 Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or reach out to a local patient advocacy group in your country or region Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #NET #EndoTwitter #LetsTalkAboutNETs"  
[X Link](https://x.com/anyuser/status/2023377321395171493)  2026-02-16T12:42Z [----] followers, [---] engagements


"Thriving beyond an EP-NEC diagnosis: Perspectives on treatment and care 📺 Video for patients & care partners From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation Explore: -EP-NEC in context -The complexity and burden of the disease -The concept of thrivership Endorsed by @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim https://x.com/net_connectinfo/status/2023007559469150615/video/1 https://x.com/net_connectinfo/status/2023007559469150615/video/1"  
[X Link](https://x.com/anyuser/status/2023007559469150615)  2026-02-15T12:12Z [----] followers, 91.8K engagements


"What do patients need to know about extrapulmonary neuroendocrine carcinoma (EP-NEC) EP-NEC is a rare and complex cancer that can be difficult to recognise diagnose and treat 📺 Watch the video to find out more about navigating EP-NEC: - Why urgency is needed in diagnosis & treatment - The potential of investigational treatments - Where to find support Endorsed by: INCA (@netcancerday) .@NECancerAus @ncukcharity @NCFCancer @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim"  
[X Link](https://x.com/anyuser/status/2023005196960325732)  2026-02-15T12:03Z [----] followers, 99.8K engagements


"Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins INCA President-Elect and CEO of NeuroEndocrine Cancer Australia to find out - Why urgency is needed in diagnosis & treatment - The potential of investigational treatments - Where to find support 🤝Endorsed by: INCA (@netcancerday) @NECancerAus @ncukcharity @NCFCancer @CureNETs & Minkahz NETs Mission See more & get the key takeaways: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd"  
[X Link](https://x.com/anyuser/status/2022348289987739703)  2026-02-13T16:33Z [----] followers, [--] engagements


"Thriving beyond an EP-NEC diagnosis: Perspectives on treatment and care 📺 Video for patients & care partners From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation Explore: -EP-NEC in context -The complexity and burden of the disease -The concept of thrivership 🤝 Endorsed by @CureNETs & Minkahz NETs Mission See more of this programme: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #OncTwitter #neuroendocrine https://cor2ed.com/net-connect/programmes/thriving-beyond-ep-nec-diagnosis/"  
[X Link](https://x.com/anyuser/status/2022222460565786753)  2026-02-13T08:13Z [----] followers, [---] engagements


"Are you an oncologist treating patients with neuroendocrine carcinoma Share your insights in this online survey: Neuroendocrine carcinoma is a highly aggressive disease and there remains a substantial need to improve clinical understanding and treatment approaches. Insights from clinicians with direct experience are essential to support ongoing research therapeutic development and patient support. We are pleased to reshare this survey thank you for sharing your perspective https://s-hab.medefield.com/wix/p815281845564.aspx Do you treat patients with Neuroendocrine Carcinoma If so we invite"  
[X Link](https://x.com/net_connectinfo/status/2020814234771173560)  2026-02-09T10:57Z [----] followers, [---] engagements


"Do you treat patients with Neuroendocrine Carcinoma If so we invite you to participate in the survey linked below. Neuroendocrine carcinoma is an aggressive disease with significant unmet clinical needs and advancing research and therapeutic development depends on insights from clinicians actively caring for these patients. Survey link: Thank you for your time and for contributing to progress in this challenging disease area. Please help us spread the word @helops79 @OncoThor @marklewismd @NVijayvergiaMD @JaydiDelRivero @OncBrothers @ajumathew_ @GlopesMd @hosein @Dr_Estelamari_R @NANETS1"  
[X Link](https://x.com/anyuser/status/2016290892660015296)  2026-01-27T23:23Z [----] followers, [----] engagements


"Exploring the role of targeted radiopharmaceutical treatment in #NETs Experts discuss PRRT and emerging strategies in #neuroendocrine tumours w/ Dr @helops79 @ProfKHerrmann Moderated by @OncBrothers 📹 Watch the video 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter https://twitter.com/i/web/status/2019777349298839874 https://twitter.com/i/web/status/2019777349298839874"  
[X Link](https://x.com/net_connectinfo/status/2019777349298839874)  2026-02-06T14:17Z [----] followers, [---] engagements


"Understanding EP-NEC: Through diagnosis treatment and support What do you need to know Video podcast from Medical Oncologist Dr @AmanChauhanMD + Neuroendocrine Patient Advocate Susan Meckler-Plummer RN Get answers to questions such as: -How are NETs and NECs different from one another -Why is there such urgency when treating EP-NECs -What needs remain for treatment -What support is available for patients and care partners 📹 Watch the highlights in this post  Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or"  
[X Link](https://x.com/net_connectinfo/status/2018674375830974771)  2026-02-03T13:14Z [----] followers, 297.6K engagements


"Unlike most NETs EP-NECs are poorly differentiated high-grade aggressive and fast-growing cancers with a need for more effective treatments But how do you distinguish between NECs and NETs And what does this mean for patients Get the answers in this video podcast 📹 Highlights in this post Watch the full video or listen on Spotify/Apple: 🤝 Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or reach out to a local patient advocacy group in your country or region Supported by an Independent Educational Grant from"  
[X Link](https://x.com/net_connectinfo/status/2018303387062747576)  2026-02-02T12:40Z [----] followers, [---] engagements


"What do patients need to know about extrapulmonary neuroendocrine carcinoma (EP-NEC) EP-NEC is a rare and complex cancer that can be difficult to recognise diagnose and treat 📺Watch the video to find out more about navigating EP-NEC: - Why urgency is needed in diagnosis & treatment - The potential of investigational treatments - Where to find support See more of this programme: 🤝Endorsed by: INCA (@netcancerday) @NECancerAus @ncukcharity @NCFCancer @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #PatientEducation"  
[X Link](https://x.com/anyuser/status/2017216475304542249)  2026-01-30T12:41Z [----] followers, [---] engagements


"Dr @helops79 @ProfKHerrmann & @OncBrothers share their perspectives on advances in the management of #neuroendocrine tumours Spotlight on the role of radioligand therapy and its impact on clinical practice 🔦 📹 Video in this post 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter #NETs"  
[X Link](https://x.com/net_connectinfo/status/2014703667870646484)  2026-01-23T14:16Z [----] followers, [---] engagements


"Understanding EP-NEC: Through diagnosis treatment and support What do the differences between NETs and NECs mean for patients Poorly differentiated high-grade aggressive cancers need urgent treatment options. Find out more in this video podcast 🎙 w/ Medical Oncologist @AmanChauhanMD & Neuroendocrine Patient Advocate Susan Meckler-Plummer RN 📹 Highlights in this post Watch the full video or listen on Spotify/Apple: 🤝 Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or reach out to a local patient advocacy group"  
[X Link](https://x.com/net_connectinfo/status/2013229201911103692)  2026-01-19T12:37Z [----] followers, [---] engagements


"There remains an unmet treatment need for extra-pulmonary neuroendocrine carcinomas but emerging clinical data with DLL3-targeted agents are promising. Alongside treatment advances access to strong support networks remains vital for patients and their care partners. Listen along in this Podcast with Medical Oncologist Dr Aman Chauhan and Patient Advocate Susan Meckler-Plummer to learn more: Spotify: Apple Podcasts: This educational programme is supported by an Independent Educational Grant from Boehringer Ingelheim"  
[X Link](https://x.com/anyuser/status/2010719499901612055)  2026-01-12T14:24Z [----] followers, [---] engagements


"➡ EP-NEC patients require expert care from specialists knowledgeable in #neuroendocrine carcinoma ➡ Generic care is insufficient to address the aggressive nature and unique challenges of this disease What else do HCPs need to know to support pts w/ extrapulmonary neuroendocrine carcinoma 📺 Watch the video to find out From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation 🤝 Endorsed by @CureNETs & Minkahz NETs Mission See more of this programme: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #OncTwitter"  
[X Link](https://x.com/anyuser/status/2009673774438682836)  2026-01-09T17:09Z [----] followers, [---] engagements


"NETs: Understanding key clinical studies like COMPETE and NETTER-1 and [---] helps you pair the right patient with the right treatment ✅ What else do you need to know about radiopharmaceutical treatment for #NETs Experts discuss management strategies future directions and more 📹 Video from Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter https://twitter.com/i/web/status/2009539388330680504 https://twitter.com/i/web/status/2009539388330680504"  
[X Link](https://x.com/anyuser/status/2009539388330680504)  2026-01-09T08:15Z [----] followers, [---] engagements


"Understanding EP-NEC: Through diagnosis treatment and support What do you need to know Video podcast from Medical Oncologist Dr @AmanChauhanMD + Neuroendocrine Patient Advocate Susan Meckler-Plummer RN Get answers to questions such as: -How are NETs and NECs different from one another -Why is there such urgency when treating EP-NECs -What needs remain for treatment -What support is available for patients and care partners 📹 Watch the highlights in this post Watch the full video or listen on Spotify/Apple:  Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more"  
[X Link](https://x.com/anyuser/status/2008154513774125414)  2026-01-05T12:32Z [----] followers, [---] engagements


"Thriving beyond an EP-NEC diagnosis: Perspectives on treatment and care 📺Video for patients & HCPs From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation 🤝 Endorsed by @CureNETs & Minkahz NETs Mission See more of this programme: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #OncTwitter https://cor2ed.com/net-connect/programmes/thriving-beyond-ep-nec-diagnosis/ https://cor2ed.com/net-connect/programmes/thriving-beyond-ep-nec-diagnosis/"  
[X Link](https://x.com/anyuser/status/2007078170965774630)  2026-01-02T13:15Z [----] followers, [---] engagements


"Thriving beyond an EP-NEC diagnosis: new video Extra-pulmonary neuroendocrine carcinoma (EP-NEC) is rare aggressive & often misunderstood/ diagnosed late This video explores: -EP-NEC in context -The complexity and burden of the disease -The concept of thrivership 📺 w/ Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation Endorsed by @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim"  
[X Link](https://x.com/anyuser/status/2005349562706440603)  2025-12-28T18:46Z [----] followers, 563.6K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing